|
PAFAH1B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.499800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.756000E-01 |
| Normal-vs-Stage2 |
2.904600E-01 |
| Normal-vs-Stage3 |
5.308200E-02 |
| Normal-vs-Stage4 |
1.964160E-03 |
| Stage1-vs-Stage2 |
4.131200E-01 |
| Stage1-vs-Stage3 |
9.134100E-02 |
| Stage1-vs-Stage4 |
2.056600E-03 |
| Stage2-vs-Stage3 |
5.158800E-01 |
| Stage2-vs-Stage4 |
6.644100E-02 |
| Stage3-vs-Stage4 |
2.442200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.536400E-01 |
| Normal-vs-AfricanAmerican |
3.247200E-01 |
| Normal-vs-Asian |
3.519000E-01 |
| Caucasian-vs-AfricanAmerican |
5.567000E-01 |
| Caucasian-vs-Asian |
5.103800E-01 |
| AfricanAmerican-vs-Asian |
5.428400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.485200E-01 |
| Normal-vs-Female |
4.908000E-01 |
| Male-vs-Female |
1.472380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.300100E-02 |
| Normal-vs-Extreme_Weight |
2.838400E-01 |
| Normal-vs-Obese |
7.141600E-01 |
| Normal-vs-Extreme_Obese |
8.613600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.466000E-01 |
| Normal_Weight-vs-Obese |
1.023610E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.157000E-01 |
| Extreme_Weight-vs-Obese |
5.367200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.156200E-01 |
| Obese-vs-Extreme_Obese |
9.566800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.169400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.143400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.193380E-01 |
| Normal-vs-Age(81-100Yrs) |
6.474300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.071000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.816800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.236240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.269500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.194300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.083800E-02 |
| Normal-VS-Type2 PRCC |
9.037400E-04 |
| Normal-VS-KIRP CIMP |
7.028300E-02 |
| Normal-VS-Unclassified PRCC |
6.706000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.54009999999905E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.479700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.126800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.586400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.720450E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.816420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.239000E-03 |
| Normal-vs-N1 |
4.978300E-02 |
| Normal-vs-N2 |
1.63850000012289E-07 |
| N0-vs-N1 |
7.548000E-01 |
| N0-vs-N2 |
5.409200E-04 |
| N1-vs-N2 |
8.953500E-04 |
|
|
